Incorporated in 1984, Bliss GVS Pharma Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups.
Financial Results:
Bliss GVS Pharma Ltd reported Revenues for Q1FY24 of ₹160.00 Crores down from ₹189.00 Crore year on year, a fall of 15.34%.
Total Expenses for Q1FY24 of ₹142.00 Crores down from ₹157.00 Crores year on year, a fall of 9.55%.
Consolidated Net Profit of ₹14.00 Crores down 48.15% from ₹27.00 Crores in the same quarter of the previous year.
The Earnings per Share is ₹1.41, down 43.15% from ₹2.48 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.